Gerd Jomrich

1.4k total citations
55 papers, 1.0k citations indexed

About

Gerd Jomrich is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gerd Jomrich has authored 55 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Surgery, 31 papers in Oncology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gerd Jomrich's work include Esophageal Cancer Research and Treatment (18 papers), Gastric Cancer Management and Outcomes (16 papers) and Pancreatic and Hepatic Oncology Research (15 papers). Gerd Jomrich is often cited by papers focused on Esophageal Cancer Research and Treatment (18 papers), Gastric Cancer Management and Outcomes (16 papers) and Pancreatic and Hepatic Oncology Research (15 papers). Gerd Jomrich collaborates with scholars based in Austria, United States and Switzerland. Gerd Jomrich's co-authors include Sebastian F. Schoppmann, Matthias Paireder, Ivan Kristo, Michael Gnant, Martin Schindl, Reza Asari, Klaus Sahora, Elisabeth S. Gruber, Matthias Preusser and Aysegül Ilhan‐Mutlu and has published in prestigious journals such as PLoS ONE, Annals of Surgery and Scientific Reports.

In The Last Decade

Gerd Jomrich

53 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerd Jomrich Austria 18 596 405 240 202 140 55 1.0k
Yukiko Niwa Japan 20 402 0.7× 405 1.0× 380 1.6× 223 1.1× 67 0.5× 41 913
Kohei Wakatsuki Japan 19 546 0.9× 513 1.3× 526 2.2× 155 0.8× 76 0.5× 56 1.1k
Seung‐Hoon Beom South Korea 17 459 0.8× 230 0.6× 361 1.5× 150 0.7× 78 0.6× 69 901
Sohei Matsumoto Japan 21 652 1.1× 606 1.5× 611 2.5× 180 0.9× 93 0.7× 64 1.3k
Youqing Zhan China 17 414 0.7× 275 0.7× 406 1.7× 112 0.6× 74 0.5× 24 817
Antonia Strippoli Italy 17 532 0.9× 328 0.8× 438 1.8× 134 0.7× 96 0.7× 66 1.1k
Kazuhiro Migita Japan 20 646 1.1× 590 1.5× 587 2.4× 127 0.6× 78 0.6× 61 1.2k
Atsushi Takeno Japan 17 271 0.5× 471 1.2× 539 2.2× 189 0.9× 118 0.8× 137 945
José Luís Hernández-Lizoáin Spain 22 638 1.1× 735 1.8× 286 1.2× 115 0.6× 73 0.5× 58 1.3k
Pengfei Kong China 19 678 1.1× 276 0.7× 381 1.6× 174 0.9× 42 0.3× 41 1.1k

Countries citing papers authored by Gerd Jomrich

Since Specialization
Citations

This map shows the geographic impact of Gerd Jomrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerd Jomrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerd Jomrich more than expected).

Fields of papers citing papers by Gerd Jomrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerd Jomrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerd Jomrich. The network helps show where Gerd Jomrich may publish in the future.

Co-authorship network of co-authors of Gerd Jomrich

This figure shows the co-authorship network connecting the top 25 collaborators of Gerd Jomrich. A scholar is included among the top collaborators of Gerd Jomrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerd Jomrich. Gerd Jomrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Leonhardt, Carl-Stephan, Dietmar Pils, Gerd Jomrich, et al.. (2023). The Revised R Status Is an Independent Predictor of Postresection Survival in Pancreatic Cancer after Neoadjuvant Treatment. HPB. 25. S284–S285. 1 indexed citations
3.
Jomrich, Gerd, Elisabeth S. Gruber, Jakob Mühlbacher, et al.. (2023). Prognostic significance of mean corpuscular volume in patients with pancreatic ductal adenocarcinoma and multimodal treatment. Journal of Visceral Surgery. 161(2). 99–105. 1 indexed citations
4.
Gensthaler, Lisa, Gerd Jomrich, Dagmar Kollmann, et al.. (2023). Preoperative BChE serves as a prognostic marker in patients with resectable AEG after neoadjuvant chemotherapy. Langenbeck s Archives of Surgery. 408(1). 227–227. 4 indexed citations
5.
Puhr, Hannah Christina, Matthias Paireder, Gerd Jomrich, et al.. (2022). Development of an alarm symptom-based risk prediction score for localized oesophagogastric adenocarcinoma (VIOLA score). ESMO Open. 7(4). 100519–100519.
6.
Marchegiani, Giovanni, Stefano Andrianello, Tommaso Pollini, et al.. (2021). The faith of non-surveilled pancreatic cysts: a bicentric retrospective study. European Journal of Surgical Oncology. 48(1). 89–94. 5 indexed citations
7.
8.
9.
Gruber, Elisabeth S., Gerd Jomrich, Alexandra Kaider, et al.. (2020). The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection. Annals of Surgical Oncology. 27(6). 2017–2024. 9 indexed citations
10.
Paireder, Matthias, Gerd Jomrich, Ivan Kristo, et al.. (2020). Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity. Strahlentherapie und Onkologie. 196(9). 779–786. 5 indexed citations
11.
Jomrich, Gerd, et al.. (2019). Expression of FGF8, FGF18, and FGFR4 in Gastroesophageal Adenocarcinomas. Cells. 8(9). 1092–1092. 14 indexed citations
12.
Kristo, Ivan, Matthias Paireder, Gerd Jomrich, et al.. (2019). Modern Esophageal Function Testing and Gastroesophageal Reflux Disease in Morbidly Obese Patients. Obesity Surgery. 29(11). 3536–3541. 33 indexed citations
13.
Kollmann, Dagmar, Desislava Ignatova, Julia Jedamzik, et al.. (2018). PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma. OncoImmunology. 7(6). e1435226–e1435226. 32 indexed citations
14.
Ahmed, Mohamed A., Gerald Timelthaler, Gerd Jomrich, et al.. (2018). FGF8 induces therapy resistance in neoadjuvantly radiated rectal cancer. Journal of Cancer Research and Clinical Oncology. 145(1). 77–86. 13 indexed citations
15.
Kollmann, Dagmar, Desislava Ignatova, Julia Jedamzik, et al.. (2017). Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal Adenocarcinoma. Annals of Surgical Oncology. 24(9). 2698–2706. 27 indexed citations
16.
Jomrich, Gerd, Gerd R. Silberhumer, Brigitte Marian, Andrea Beer, & Leonhard Müllauer. (2016). Programmed death-ligand 1 expression in rectal cancer. European surgery. Supplement/European surgery. 48(6). 352–356. 16 indexed citations
17.
Jomrich, Gerd & Sebastian F. Schoppmann. (2015). Targeting HER 2 and angiogenesis in gastric cancer. Expert Review of Anticancer Therapy. 16(1). 111–122. 15 indexed citations
18.
Schoppmann, Sebastian F., Ursula Vinatzer, Niko Popitsch, et al.. (2013). Novel Clinically Relevant Genes in Gastrointestinal Stromal Tumors Identified by Exome Sequencing. Clinical Cancer Research. 19(19). 5329–5339. 28 indexed citations
19.
Schoppmann, Sebastian F., et al.. (2012). Phosphorylation of signal transducer and activator of transcription 3 (STAT3) correlates with Her-2 status, carbonic anhydrase 9 expression and prognosis in esophageal cancer. Clinical & Experimental Metastasis. 29(6). 615–624. 38 indexed citations
20.
Marschalek, Julian, Georg Györi, Gerd R. Silberhumer, et al.. (2012). Simultaneous Pancreas-Kidney Transplantation Nine Years After Liver Transplantation—A Case Report. Transplantation Proceedings. 44(10). 3041–3043. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yukiko Niwa Breakdown of academic impact, for papers by Kohei Wakatsuki Breakdown of academic impact, for papers by Seung‐Hoon Beom Breakdown of academic impact, for papers by Sohei Matsumoto Breakdown of academic impact, for papers by Youqing Zhan Breakdown of academic impact, for papers by Antonia Strippoli Breakdown of academic impact, for papers by Kazuhiro Migita Breakdown of academic impact, for papers by Atsushi Takeno Breakdown of academic impact, for papers by José Luís Hernández-Lizoáin Breakdown of academic impact, for papers by Pengfei Kong
Rankless by CCL
2026